The
global Intravenous
Solutions Market size is expected to reach USD 22.01 billion by
2030, registering a CAGR of 8.0% according to a new report by Grand View
Research, Inc. The growing incidence rate of chronic diseases such as
cancer, increase in the number of premature births, and shortage of I.V.
solutions in the U.S. are some of the key factors expected to drive the market.
One
of the prime areas wherein intravenous (IV) fluids find usage is severe
dehydration. Severe dehydration is seen in diseases such as diarrhea, resulting
in the depletion of fluids from the body. According to the WHO, in 2017,
diarrhea was the second leading cause of death in children under 5 years of age
with around 5,25,000 lives lost each year. Intravenous (IV) fluids can play a
key role in the treatment and prevention of deaths caused due to
dehydration/fluid loss associated with diarrhea. Other cases where intravenous
fluids find application include surgeries and emergencies.
The
ongoing COVID-19 pandemic is expected to have a positive impact on the market.
Intensive Care Units (ICU) worldwide are either operating at full capacity or
are overcrowded due to the high influx of patients infected with severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). As per an article published by
BBC, in January 2021, critical care wards across England were running at full
capacity. Nutritional care is one of the essential elements in managing these
patients. This has increased the demand for intravenous (IV) fluids, as many of
the patients, especially the elderly population are placed on ventilators and
are unable to consume food orally.
Related Press
Release@ Intravenous
Solutions Market Report
Intravenous Solutions Market Report Highlights
- The Total
Parenteral Nutrition (TPN) segment led the segment in terms of revenue share
in 2020 owing to its growing applications in the management of chronic
diseases
- The
increasing number of surgeries and post-operative nutritional management
is a prime factor driving the vitamins and minerals (salt and electrolyte)
segment’s growth
- North
America dominated the market with a revenue share of nearly 40.8% in 2020
due to the high usage of IV fluids in the U.S.
About Us:
Grand View Research, Inc. is a U.S. based market
research and consulting company, registered in the State of California and
headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, the company offers market intelligence
studies ensuring relevant and fact-based research across a range of industries
including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment